Evidence map›Paper›PMID 37291502›Full record

ArticleBMC pulmonary medicine2023

Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study.

Olga Ochoa-Gondar, Verónica Torras-Vives, Cinta de Diego-Cabanes, Eva M Satué-Gracia, Angel Vila-Rovira, María J Forcadell-Perisa, Domingo Ribas-Seguí, Clara Rodríguez-Casado, Angel Vila-Córcoles

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Genomic characterization of invasiveMicrobial genomics · 2026
    Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. [Recommendations on prevention and treatment of respiratory infections in institutionalised older people].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Olga Ochoa-GondarPrimary Health Care Service "Camp de Tarragona", Institut Català de la Salut, Tarragona, Spain.
Verónica Torras-VivesPrimary Health Care Service "Camp de Tarragona", Institut Català de la Salut, Tarragona, Spain.
Cinta de Diego-CabanesPrimary Health Care Service "Camp de Tarragona", Institut Català de la Salut, Tarragona, Spain. mcdiego.tgn.ics@gencat.cat.
Eva M Satué-GraciaPrimary Health Care Service "Camp de Tarragona", Institut Català de la Salut, Tarragona, Spain.
Angel Vila-RoviraPrimary Health Care Service "Camp de Tarragona", Institut Català de la Salut, Tarragona, Spain.
María J Forcadell-PerisaPrimary Health Care Service "Camp de Tarragona", Institut Català de la Salut, Tarragona, Spain.
Domingo Ribas-SeguíPrimary Health Care Service "Camp de Tarragona", Institut Català de la Salut, Tarragona, Spain.
Clara Rodríguez-CasadoInformation System for the Improvement of Research in Primary Care (SIDIAP), Primary Care Research Institute Jordi Gol, Universitat Autonoma de Barcelona, Barcelona, Spain.
Angel Vila-CórcolesPrimary Health Care Service "Camp de Tarragona", Institut Català de la Salut, Tarragona, Spain.
Institut Català de la Salut · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESUniversitat Autònoma de Barcelona · ES

Funding

This work was supported by a grant from the "Fondo de Investigación Sanitaria" of the "Instituto de Salud Carlos III" (call 2020) for the "Acción Estratégica en Salud 2020/2030 (code file PI20/01223), cofinanced by the European Union through the "Fondo Europeo de Desarrollo Regional" (FEDER). code file PI20/01223
6 · The paper itself

Abstract

backgroundInfection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and without specific underlying conditions/comorbidities, examining the influence of single and multi-comorbidities in the risk of suffering PP.

methodsPopulation-based cohort study involving 2,059,645 persons ≥ 50 years-old in Catalonia, Spain, who were retrospectively followed between 01/01/2017-31/12/2018. The Catalonian information system for development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities/underlying conditions), and PP cases were collected from discharge codes (ICD-10: J13) of the 68 referral Catalonian hospitals.

resultsGlobal incidence rate (IR) was 90.7 PP cases per 100,000 person-years, with a 7.6% (272/3592) case-fatality rate (CFR). Maximum IRs emerged among persons with history of previous IPD or all-cause pneumonia, followed by haematological neoplasia (475.0), HIV-infection (423.7), renal disease (384.9), chronic respiratory disease (314.7), liver disease (232.5), heart disease (221.4), alcoholism (204.8), solid cancer (186.2) and diabetes (159.6). IRs were 42.1, 89.9, 201.1, 350.9, 594.3 and 761.2 in persons with 0, 1, 2, 3, 4 and ≥ 5 comorbidities, respectively. In multivariable analyses, HIV-infection (hazard ratio [HR]: 5.16; 95% CI: 3.57-7.46), prior all-cause pneumonia (HR: 3.96; 95% CI: 3.45-4.55), haematological neoplasia (HR: 2.71; 95% CI: 2.06-3.57), chronic respiratory disease (HR: 2.66; 95% CI: 2.47-2.86) and prior IPD (HR: 2.56; 95% CI: 2.03-3.24) were major predictors for PP.

conclusionApart of increasing age and immunocompromising conditions (classically recognised as high-risk conditions), history of prior IPD/pneumonia, presence of chronic pulmonary/respiratory disease and/or co-existing multi-comorbidity (i.e., two or more underlying conditions) are major risk factors for PP in adults, with an excess risk near to immunocompromised subjects. Redefining risk categories for PP, including all the above-mentioned conditions into the high-risk category, could be necessary to improve prevention strategies in middle-aged and older adults.

Indexed as

NeoplasmsPneumococcal InfectionsPneumonia, PneumococcalAgedCohort StudiesHumansIncidenceMiddle AgedPneumococcal VaccinesRetrospective StudiesRisk FactorsPneumococcal VaccinesAdultsIncidenceMultimorbidityPneumococcal pneumoniaRisk factors

Identifiers

PMID37291502
PMCPMC10251659
OpenAlexW4379880350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.